Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for Ceritinib

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, September 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,389 followers.

Personalized treatment options for ALK-positive metastatic NSCLC http://t.co/bMbWZkesR8

Personalized treatment options for ALK-positive metastatic NSCLC http://t.co/MQa4rc5FKg